The U.S. is inching closer to approving vaccines. Two developers, Moderna and Pfizer, are applying for emergency authorization for their versions from the Food and Drug Administration. Oxford University and pharmaceutical giant AstraZeneca are also developing a vaccine.
The Trump administration has said the U.S. could start giving out vaccines as early as mid-December, though Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said it’s likely one won’t be widely available until April 2021.
